|
| Cynomolgus NKG2C/CD159c Protein (LTP10454) |
|
| LTP10454 |
|
| 100ug |
|
|
$519 In stock |
| As a first line of defense, natural killer (NK) cells play a crucial role in the fight against infections. The presented study is the first of its kind that ascribes CD56dimCD16 NKG2C-expressing NK cells a crucial role in biasing adaptive immune responses upon influenza vaccination and suggests NKG2C as a potential biomarker in predicting pandemic influenza vaccine responsiveness. |
| Recombinant Cynomolgus NKG2C/CD159c Protein is expressed from Expi293 with His tag at the N-terminal. It contains Ile94-Leu231. |
|
| NKG2C/CD159c |
|
| Cynomolgus |
|
| Q68VD0-1 |
|
| Ile94-Leu231 |
|
| The protein has a predicted MW of 16.9 kDa. Due to glycosylation, the protein migrates to 25-30 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| N-His |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
